Abstract
In the present study, 3D-QSAR analysis was performed on a set of 37 TGF-β inhibitors utilizing pharmacophore based alignment to uncover the essential structural and steric features of these newly discovered b-annulated 1,4- dihydropyridine (1,4-DHP) molecules to get better antagonism of the TGF-β receptor. The best 3D-QSAR model identified with PLS factor 4 that had the highest values of external predictability parameters exhibited Q2 (0.8972), and R2 (0.9826) and displayed high values of F (281.9) and low SD (0.0785). This selected model was validated statistically by determining Pearson-r (0.9718) for test set molecules. Contours thus obtained from different properties generated using our QSAR model explained the variation in the activity of dataset with respect to different attachments in the core structure. This would help to make suitable structural modifications in 1, 4-DHP molecules so as to make a better complementary fit to the active site of TGF-β receptor, which in turn would improve the potency of newly designed molecules.
Keywords: Atom based QSAR, Pharmacophore, TGFβ signalling, Cardiogenesis.
Letters in Drug Design & Discovery
Title:Pharmacophore and 3D QSAR Study of TGFβ Inhibitors
Volume: 11 Issue: 3
Author(s): Mohamed Asraf Vazhapully, D. Vinod and N.H. Zeinul Hukuman
Affiliation:
Keywords: Atom based QSAR, Pharmacophore, TGFβ signalling, Cardiogenesis.
Abstract: In the present study, 3D-QSAR analysis was performed on a set of 37 TGF-β inhibitors utilizing pharmacophore based alignment to uncover the essential structural and steric features of these newly discovered b-annulated 1,4- dihydropyridine (1,4-DHP) molecules to get better antagonism of the TGF-β receptor. The best 3D-QSAR model identified with PLS factor 4 that had the highest values of external predictability parameters exhibited Q2 (0.8972), and R2 (0.9826) and displayed high values of F (281.9) and low SD (0.0785). This selected model was validated statistically by determining Pearson-r (0.9718) for test set molecules. Contours thus obtained from different properties generated using our QSAR model explained the variation in the activity of dataset with respect to different attachments in the core structure. This would help to make suitable structural modifications in 1, 4-DHP molecules so as to make a better complementary fit to the active site of TGF-β receptor, which in turn would improve the potency of newly designed molecules.
Export Options
About this article
Cite this article as:
Vazhapully Asraf Mohamed, Vinod D. and Hukuman Zeinul N.H., Pharmacophore and 3D QSAR Study of TGFβ Inhibitors, Letters in Drug Design & Discovery 2014; 11 (3) . https://dx.doi.org/10.2174/157018081131000071
DOI https://dx.doi.org/10.2174/157018081131000071 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Management and Treatment of Cerebral Vasospasm Complicating SAH
CNS & Neurological Disorders - Drug Targets The Predictive Value of Lipid Markers in Vascular Disease
Current Pharmaceutical Design Emerging Technologies in Biocompatible Surface Modifying Additives: Quest for Physiologic Cardiopulmonary Bypass
Current Medicinal Chemistry - Cardiovascular & Hematological Agents The CX3C-Chemokine Fractalkine in Kidney Diseases
Mini-Reviews in Medicinal Chemistry “Bridge Proteins” Link Inflammation and Metabolic Diseases: Potential Targets for Therapeutics
Current Protein & Peptide Science Acute Kidney Injury after Complex Endovascular Aneurysm Repair
Current Pharmaceutical Design Pathophysiology of Cardiovascular Diseases and the Role of Vitamins, and Herbal Extracts in the Reduction of Cardiovascular Risks
Cardiovascular & Hematological Agents in Medicinal Chemistry Recent Advances in Management of Diabetic Macular Edema
Current Diabetes Reviews Cerebral Aneurysm as an Exacerbating Factor in Stroke Pathology and a Therapeutic Target for Neuroprotection
Current Pharmaceutical Design The Simulation and Experimental Comparison of Parameter Factors Impact on MRI Artifact
Current Medical Imaging Antibody Targeting of TGF-β in Cancer Patients
Current Pharmaceutical Biotechnology Anesthetic Considerations for Electroconvulsive Therapy-Especially Hemodynamic and Respiratory Management
Current Psychiatry Reviews Oral Angiotensin-(1-7) Peptide Modulates Intestinal Microbiota Improving Metabolic Profile in Obese Mice
Protein & Peptide Letters Update on the Imaging Techniques in the Diagnosis of Diabetic Retinopathy
Current Diabetes Reviews Mechanisms of Improvement of Left Ventricular Function by Intracoronary Human Umbilical Cord-Derived Mesenchymal Stem Cell Infusion in Very Old Patients with Coronary Chronic Total Occlusion
Current Pharmaceutical Design Adipose Tissue and Bone Marrow as Sources for Cell-based Therapeutic Angiogenesis in Ischemic Tissues: Biological Foundation and Clinical Prospects for Age-related Vascular Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Recent Advances in Receptor-Targeted Fluorescent Probes for In Vivo Cancer Imaging
Current Medicinal Chemistry Effect of β-Blockers on Perioperative Myocardial Ischemia in Patients Undergoing Noncardiac Surgery
Current Drug Targets Newly Diagnosed Dementia and Increased Risk of Hemorrhagic Stroke: A Nationwide Population-based Study
Current Alzheimer Research Usefulness of Magnetic Resonance Imaging in Cardiac and Enovascular Intervention
Current Medical Imaging